Interpreting the serotonin blood pressure paradox: An updated integrative framework for hypertension

Abstract Background Serotonin (5-hydroxytryptamine) contributes to cardiovascular regulation through central and peripheral mechanisms, yet its reported effects on vascular tone, autonomic control, platelet function, renal physiology and arterial pressure are often opposing. We use the term ‘serotonin blood pressure paradox’ as an author-defined descriptive construct for these context-dependent observations rather than as a distinct clinical entity or single mechanism. Methods A structured narrative search of PubMed/MEDLINE, Scopus, Web of Science and Google Scholar was updated till 19 August 2026. Relevant data were selected with priority given to human studies, narratively extracted and synthesised according to evidence context; animal and in vitro studies addressed mechanisms insufficiently characterised clinically. Results Serotonergic cardiovascular effects are best interpreted within a distributed regulatory network involving autonomic pathways, vascular receptors, platelet serotonin handling and the serotonin transporter, endothelial and renal physiology, gut microbiota, serotonylation and genetic background. Their direction varies across biological compartment, context and time. Human evidence supports several vascular, platelet, renal, genetic and pharmacological associations, whereas microbiota-dependent mechanisms and serotonylation in systemic hypertension remain supported mainly by experimental or translational data. Circulating serotonin measurements are additionally limited by substantial pre-analytical variability. Conclusions The paradox is better understood as context-dependent serotonergic cardiovascular regulation than as a contradiction requiring a single mechanistic resolution. The proposed framework is interpretative and hypothesis-generating; current evidence does not establish serotonin as a dominant causal pathway, validated biomarker or specific therapeutic target in systemic arterial hypertension.

Authors

Institutions

Publication Details

Journal
Romanian Journal of Cardiology
Published
2026-11-06
DOI
https://doi.org/10.2478/rjc-2026-0032
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Interpreting the serotonin blood pressure paradox: An updated integrative framework for hypertension

А. В. Чорномидз, Yurii Chornomydz, Oleksandra Oleshchuk
Romanian Journal of Cardiology
Blood Pressure and Hypertension Studies
article

Interpreting the serotonin blood pressure paradox: An updated integrative framework for hypertension

А. В. Чорномидз, Yurii Chornomydz, Oleksandra Oleshchuk
article en

Abstract

Abstract Background Serotonin (5-hydroxytryptamine) contributes to cardiovascular regulation through central and peripheral mechanisms, yet its reported effects on vascular tone, autonomic control, platelet function, renal physiology and arterial pressure are often opposing. We use the term ‘serotonin blood pressure paradox’ as an author-defined descriptive construct for these context-dependent observations rather than as a distinct clinical entity or single mechanism. Methods A structured narrative search of PubMed/MEDLINE, Scopus, Web of Science and Google Scholar was updated till 19 August 2026. Relevant data were selected with priority given to human studies, narratively extracted and synthesised according to evidence context; animal and in vitro studies addressed mechanisms insufficiently characterised clinically. Results Serotonergic cardiovascular effects are best interpreted within a distributed regulatory network involving autonomic pathways, vascular receptors, platelet serotonin handling and the serotonin transporter, endothelial and renal physiology, gut microbiota, serotonylation and genetic background. Their direction varies across biological compartment, context and time. Human evidence supports several vascular, platelet, renal, genetic and pharmacological associations, whereas microbiota-dependent mechanisms and serotonylation in systemic hypertension remain supported mainly by experimental or translational data. Circulating serotonin measurements are additionally limited by substantial pre-analytical variability. Conclusions The paradox is better understood as context-dependent serotonergic cardiovascular regulation than as a contradiction requiring a single mechanistic resolution. The proposed framework is interpretative and hypothesis-generating; current evidence does not establish serotonin as a dominant causal pathway, validated biomarker or specific therapeutic target in systemic arterial hypertension.

Romanian Journal of Cardiology
I.Horbachevsky Ternopil National Medical University (UA)
Good health and well-being
Openalex Percentile: Top 13%
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon